featured
Discontinuation of Infliximab and Risk of Relapse in Patients With Sustained Complete Remission of Crohn’s Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles: